Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 937 results for "mylan"

What Is Mylan NV Next Move?

Mylan NV's ( NASDAQ:MYL ) chief financial officer, John Sheehan, visited Israel today to meet Yossi Beinart, the head of Tel Aviv Stock Exchange. The meeting was expected to be conducted to talk about a possible listing of Mylan's shares on the ... Bidness Etc, 1 week ago

671 images for mylan

WKRB News, 3 days ago
SleekMoney, 4 days ago
Ticker Report, 4 days ago
Globes, 6 days ago
SleekMoney, 1 week ago, 4 days ago, 4 days ago
Mideast Time, 2 weeks ago
Ticker Report, 2 weeks ago
Pittsburgh Post-Gazette, 2 weeks ago

Maneuvers and Dutch defenses that may complicate Mylan-Teva takeover war

The war between generic drug makers Teva Pharmaceutical Industries and Mylan shows how takeovers are becoming more hostile as major industries consolidate. The fate of Mylan's rejected $33 billion bid for Perrigo earlier this year is in question, as ...
 Pharmacist.com1 week ago Teva buys 4.61% interest in Mylan NV  Bloomberg1 week ago Teva Takes 4.6% Stake in Mylan  Investors Hub1 week ago "Teva's Mylan stake a psychological factor"  Globes1 week ago

EU regulators to rule on Mylan bid for Perrigo by July 29

BRUSSELS, June 25 Mylan's offer is seen as a move to head off world No. 1 generic drugmaker Teva Pharmaceutical Industries in a high-profile takeover battle. The Commission said Mylan requested EU clearance for its Perrigo bid on Tuesday. The EU ...
 Reuters1 week ago
MSN India

Mylan rejects drug company Teva's $40.1 billion buyout offer

Mylan N.V.rejected Teva Pharmaceuticals' $40.1 billion buyout offer, saying the cash-and-stock proposal undervalues the company.
 Times of India2 months ago Mylan rejects Teva's $40 billion offer  MSN India2 months ago Mylan rejects Teva's $40.1 bn buyout offer, but leaves door open  Economic Times2 months ago Teva's $40 bn offer to buy Mylan could transform generics space: GlobalData  Business Standard2 months ago
Business Standard

Cipla declines on negative outlook from a foreign brokerage

Cipla fell 1.57% to Rs 604.40 at 10:24 IST on BSE on reports a foreign brokerage said that launch of asthma drug by Mylan in the UK is negative for Cipla because Cipla was earlier expected to be the first company to launch this drug. Meanwhile, the S BSE ...
 Business Standard3 weeks ago Mylan's Asthma drug launch in UK negative for Cipla: BoAML  Money Control3 weeks ago Cipla drops on Mylan's asthma drug launch  Business Standard3 weeks ago

Mylan recalls Bangalore unit cancer drug

US co recalling two drugs manufactured by Agila Onco, which it bought from Strides Arcolab two years back
 DNA2 weeks ago
India Infoline

Mylan launches generic asthma inhaler in UK

that it had launched the first bioequivalent alternative to GlaxoSmithKline (GSK)'s asthma inhaler Seretide/Advair (fluticasone/salmeterol) in
 GaBi Online1 day ago Cipla loses 3% as Mylan launches generic Seretide  Economic Times3 weeks ago Cipla drops as Mylan launches asthma drug  India Infoline3 weeks ago Cipla slips as rival Mylan launches generic Seretide in UK's $400-mn anti-asthma drug market  Economic Times3 weeks ago
Money Control

Mylan launches hepatitis-C Sovaldi tablets in India

HYDERABAD: Pharma giant Mylan NV today said its subsidiary Mylan Pharmaceuticals has launched Gilead Sciences' Sovaldi (sofosbuvir 400mg tablets) in the country. Sovaldi is used for the treatment of chronic hepatitis-C infection as a component of a ...
 Economic Times2 months ago Mylan launches Sovaldi tablets in India  Business Standard2 months ago

Mylan, Teva push on despite rejections from Perrigo

Israel's generics giant Teva restated its interest in buying Mylan despite a blistering rejection from Mylan earlier this week. NEW YORK: Suitors in the generic drug industry's big consolidation push signaled Wednesday they would keep fighting for deals, even ...
 Economic Times2 months ago Big pharma deals: Mylan raises bid for Perrigo to $35.6 billion  Economic Times2 months ago Big deals: Mylan, Teva push on despite rejections  Economic Times2 months ago Big pharma deals: Mylan, Teva push on despite rejections  Economic Times2 months ago
Business Standard

Mylan launches anti-hepatitis drug in India

Drug is used in treatment of chronic hepatitis C infection Dasarath Reddy | Hyderabad May 4, 2015 Last Updated at 11:20 IST Mylan Pharmaceuticals, the Indian subsidiary of US generics pharmaceutical major Mylan NV, has launched anti-hepatitis drug Sovaldi ...
 Business Standard2 months ago Mylan launches Generic Sofosbuvir Tablets in India  India Infoline2 months ago Mylan launches generic hepatitis C drug MyHep in India  Business Standard2 months ago Mylan launches hepatitis C drug MyHep in India  Economic Times2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - mylan
Get updated on latest news & your favorite topics right in your inbox!
More     Less